Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

NCT02244216 · clinicaltrials.gov ↗

COMPLETED

Status

2914

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Berotec® N 100 µg Metered-dose Inhaler

Sponsor

Boehringer Ingelheim